Academic Journal
Q1Thorax
About Thorax
Thorax is a scholarly journal published by BMJ Publishing Group. SCImago 2025 places it in Q1 with an SJR of 2.479 and an H-index of 270.
Its listed coverage is 1946-2026 and its research categories include Pulmonary and Respiratory Medicine (Q1). The 2025 dataset reports 234 documents and 3586 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Respiratory Support and Mechanisms, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Respiratory and Cough-Related Research, Lung Cancer Diagnosis and Treatment.
Recent Research Articles
Latest publications matched automatically by ISSN.
Acute cardiorespiratory responses to low-load blood-flow restriction vs high-load resistance exercise in COPD: a randomised crossover trial
Manuel Kuhn, Christian F Clarenbach, Adrian Kläy, Malcolm Kohler et al.
2026-08-26 · DOI: 10.1136/thorax-2026-225047Mucus plugs in COPD: another reason for not losing weight?
Jørgen Vestbo
2026-08-25 · DOI: 10.1136/thorax-2026-225548Journal club
Muhammad Sameed
2026-08-25 · DOI: 10.1136/thorax-2026-225858Impact of sex, socioeconomic deprivation, ethnicity and region on exacerbation rates and mortality of chronic respiratory diseases in England: population-based cohorts
Hannah Whittaker, Thomas Bolton, Ian Sinha, Liam G Heaney et al.
2026-08-20 · DOI: 10.1136/thorax-2026-224765Pulmonary embolism following mycoplasma pneumoniae infection in a child
Guodong Ding, Suling Wu, Yutong Gu, Angela Vinturache et al.
2026-08-20 · DOI: 10.1136/thorax-2026-225225Association of pulmonary artery radiation with pulmonary hypertension after lung cancer radiotherapy
Katelyn M Atkins, Samuel C Zhang, Christopher E Kehayias, Christian Guthier et al.
2026-08-20 · DOI: 10.1136/thorax-2025-224178Persistence of static lung hyperinflation in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
Théo Dhote, Clémence Martin, Isabelle Fajac, Frédérique Aubourg et al.
2026-08-18 · DOI: 10.1136/thorax-2026-225174Molecular scissors for inflamed lungs: targeting ubiquitin-specific peptidases in acute lung injury
Hannah Rose McLeod, Suguru Yamamoto, Koichi Yuki
2026-08-14 · DOI: 10.1136/thorax-2026-225655Body composition is associated with nintedanib-related diarrhoea: risk stratification in idiopathic pulmonary fibrosis
Ilaria Bassi, Marco Carpano, Gilda Giancotti, Anna Guerrieri et al.
2026-08-07 · DOI: 10.1136/thorax-2026-225408Visible mould and blood inflammatory phenotypes of asthma in adults: the CONSTANCES cohort
Tajidine Tsiavia, Joseph Henny, Emilie Fréalle, Marcel Goldberg et al.
2026-08-07 · DOI: 10.1136/thorax-2026-225328Optimal timing, duration and sequencing of therapy for progressive pulmonary fibrosis: the urgent need to move beyond the ‘wait-to-fail’ paradigm
Adhnan Omar, Philip Evans, Nicola Hutchinson
2026-08-07 · DOI: 10.1136/thorax-2026-225299Minimum important difference for the incremental shuttle walk test in long covid rehabilitation
Molly M Baldwin, Enya Daynes, Rachael A Evans, Sally J Singh et al.
2026-08-05 · DOI: 10.1136/thorax-2026-225151Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial
Rebecca H McLeese, Brenda O’Neill, Daniel F McAuley, Mike Clarke et al.
2026-08-05 · DOI: 10.1136/thorax-2025-224572Breathing immunity into in vitro lung models
Ali Doryab, Motaharehsadat Heydarian, Clare Bryant, Andrew Conway Morris et al.
2026-08-05 · DOI: 10.1136/thorax-2026-225369Unsupervised home spirometry versus supervised clinic spirometry: analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis
Ryan McChrystal, Rebecca H McLeese, Brenda O’Neill, Daniel F McAuley et al.
2026-08-05 · DOI: 10.1136/thorax-2026-225189Secondary pulmonary alveolar proteinosis mimicking ILD progression in anti-MDA5 dermatomyositis
Hirotoshi Yasui, Ko Ohara, Kaito Sano, Yasutaka Mori et al.
2026-07-31 · DOI: 10.1136/thorax-2026-225260Inhaled and oral corticosteroid use and the risk of pulmonary aspergillosis: a Danish population-based case–control study
Alexander Jordan, Louise Lindhardt Toennesen, Bård-Emil Vang Gundersen, Jens-Ulrik Stæhr Jensen et al.
2026-07-31 · DOI: 10.1136/thorax-2026-225007Corticosteroids in COPD carry the danger of fatal aspergillosis
David W Denning
2026-07-31 · DOI: 10.1136/thorax-2026-225545Familial associations of lung function between parents, offspring and siblings: a two-generation study of the ECRHS and RHINESSA cohorts
Lucia Cestelli, Simone Accordini, Andrei Malinovschi, Bryndis Benediktsdóttir et al.
2026-07-29 · DOI: 10.1136/thorax-2026-225219Effect of maintenance macrolide de-escalation during the Australian summer on exacerbations of obstructive airway diseases: a randomised, double-blind, placebo-controlled trial
Dennis Thomas, Vanessa McDonald, Peter AB Wark, Shyamala Pradeepan et al.
2026-07-28 · DOI: 10.1136/thorax-2025-224164Reviews
Community Reviews
Version History
September 8, 2026 at 12:08 am
September 8, 2026